43 / 60
Page 43
conferenceseries
.com
Volume 09
Journal of Gastrointestinal & Digestive System
ISSN: 2161-069X
Gastro Congress 2019
July 08-09, 2019
July 08-09, 2019 | Zurich, Switzerland
14
th
Euro-Global Gastroenterology Conference
Liver disease and pharmacotherapy for alcoholism
Mike McDonough
Western Hospital, Australia
A
common clinical question to addiction specialists concerns whether a medication to treat a patient’s alcoholism
should be used and if so, when could such be commenced given the patient has liver disease. Alcohol consumption
itself is a principal driver of alcoholic liver disease and as such, should prompt treatment intervention. While there
is a reasonable evidence for medications that treat alcoholism, very little evidence exists to guide the decision to
use such medication in the presence of clinically significant liver disease. This presentation reviews recent literature
on pharmacotherapy for alcohol dependence relating particularly to patients having comorbid liver disease and
alcoholism. It concludes with an outline for a Risk versus Benefit approach to pharmacotherapy decision-making.
michael.mcdonough@wh.org.auJ Gastrointest Dig Syst 2019, Volume 09